Adrian J. Mogg

Adrian J. Mogg

Auto-generated profile, based on publicly available information

Adrian J. Mogg

Eli Lilly and Co, Windlesham GU20 6PH, UK

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2008 in Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
RZRuud Zwart
Ruud Zwart
ACAnna L. Carbone
Anna L. Carbone
MMMirko Moroni
Mirko Moroni
IBIsabel Bermudez
Isabel Bermudez
AMAdrian J. Mogg
Adrian J. Mogg
ESEmanuele Sher
Emanuele Sher
Sazetidine-A has been recently proposed to be a “silent desensitizer” of α4β2 nicotinic acetylcholine receptors (nAChRs), implying that it desensitizes α4β2 nAChRs without first activating them. This unusual pharmacological property of sazetidine-A makes it, potentially, an excellent research tool to distinguish between the role of activation and desensitization of α4β2 nAChRs in mediating the central nervous system effects of nicotine itself, as well as those of new nicotinic drugs. We were surprised to find that sazetidine-A potently and efficaciously stimulated nAChR-mediated dopamine release from rat striatal slices, which is mediated by α4β2* and α6β2* subtypes of nAChR. The agonist effects on native striatal nAChRs prompted us to re-examine the effects of sazetidine-A on recombinant α4β2 nAChRs in more detail. We expressed the two alternative stoichiometries of α4β2 nAChR in Xenopus laevis oocytes and investigated the agonist properties of sazetidine-A on both α4(2)β2(3) and α4(3)β2(2) nAChRs. We found that sazetidine-A potently activated both stoichiometries of α4β2 nAChR: it was a full agonist on α4(2)β2(3) nAChRs, whereas it had an efficacy of only 6% on α4(3)β2(2) nAChRs. In contrast to what has been published before, we therefore conclude that sazetidine-A is an agonist of native and recombinant α4β2 nAChRs but shows differential efficacy on α4β2 nAChRs subtypes.

13 May 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
Shuiyu LuShuiyu Lu
Shuiyu Lu
MHMohammad Haskali
Mohammad Haskali
KRKevin M. Ruley
Kevin M. Ruley
NDNicolas J.-F. Dreyfus
Nicolas J.-F. Dreyfus
SDSusan L. DuBois
Susan L. DuBois
VPVictor Pike
Victor Pike
Two radioligands, [ 18 F]LSN3316612 and [ 11 C]LSN3316612, image and quantify brain O -linked-β- N -acetyl-glucosamine hydrolase in vivo.

1 October 2018 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
LBLisa Broad
Lisa Broad
HSHelen E Sanger
Helen E Sanger
AMAdrian J Mogg
Adrian J Mogg
ECEllen M Colvin
Ellen M Colvin
RZRuud Zwart
Ruud Zwart
PGPaul J Goldsmith
Paul J Goldsmith